Keyphrases
Neuromuscular Disease
100%
Two Dimensional
100%
Combinatorial Screening
100%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
66%
Aminoglycosides
66%
Human Plasma
66%
RNA Stem-loop
51%
Muscular Dystrophy
44%
Pediatric
37%
Internal Loop
33%
Iron Deficiency Anemia
33%
Cerebrospinal Fluid
33%
Meningitis-retention Syndrome
33%
Pediatric Case Report
33%
Complementary Medicine
33%
Short Hairpin RNA (shRNA)
33%
Mass Spectrometry Methods
33%
Health Centers
33%
Penn State
33%
Aprepitant
33%
COVID-19
33%
Neuromuscular Manifestations
33%
Loop Interaction
33%
Nusinersen
33%
Ommaya Reservoir
33%
Neurokinin-1 Receptor Antagonist
33%
Fluconazole
33%
Elsberg Syndrome
33%
Acylate
33%
MS Method
33%
Candida Infection
33%
Rhesus Macaque
33%
Hairpin
33%
Tobramycin
31%
Hairpin Loop
31%
COVID-19 Pandemic
22%
Two-tailed
20%
Small Molecules
17%
RNA Motif
15%
Medicine Use
13%
Caregivers
13%
Restrictive Lung Disease
11%
Clinical Care
11%
Spinal muscular Atrophy
11%
Vulnerable Populations
11%
Peripheral Nerve Defect
11%
Neurocognitive Impairment
11%
Congenital Myasthenic Syndrome
11%
Developmental Delay
11%
RNA Sequencing (RNA-seq)
11%
Medicine and Dentistry
Neuromuscular Disorder
66%
Pediatrics
46%
Muscular Dystrophy
40%
Apoplexy
33%
Complementary and Alternative Medicine
33%
Health Status
33%
Ommaya Reservoir
33%
COVID-19
33%
Hypochromic Anemia
33%
Muscle Disease
33%
Neuromuscular Disease
21%
Radiculitis
16%
Transverse Myelitis
16%
Prevalence
13%
Patient Safety
11%
Infection
11%
Psychomotor Retardation
11%
Infancy
11%
Health Care Cost
11%
Antisense Oligonucleotide
11%
Fluoroscopy
11%
Autosomal Recessive Inheritance
11%
Disease Modifying Therapy
11%
Brain Ischemia
11%
Developmental Delay
11%
Motor Performance
11%
Pediatrics Patient
6%
Restrictive Lung Disease
6%
Disease
6%
Telerehabilitation
6%
Myocardial Disease
6%
Telemedicine
6%
Vulnerable Population
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Diseases
6%
Scoliosis
6%
Neuropathy
6%
